Project description
Chronic wound therapy in a tube will soon promote healing safely, simply and effectively
Chronic wounds represent a significant socioeconomic burden impacting patients and healthcare systems. This burden is likely to increase given a growing proportion of elderly people and an increasing prevalence of lifestyle-related diseases such as cancer and diabetes. Improved treatments are desperately needed to avoid potentially devastating consequences. The Swiss company Stratpharma has developed a range of topical gel-based film-forming wound dressings that are also able to deliver drugs to the wound to promote healing. With EU funding of the StrataGRT project, the team is enhancing their proprietary formulation for application to chronic wounds. The project will enable product finalisation as well as scaling up of manufacturing processes and a comprehensive business plan to get it to patients quickly.
Fields of science
Programme(s)
Call for proposal
H2020-SMEInst-2018-2020-1
See other projects for this call
Funding Scheme
SME-1 - SME instrument phase 1
Coordinator
4051 Basel
Switzerland
